AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SANTANDER UK PLC

Regulatory Filings Apr 27, 2018

4587_rns_2018-04-27_dd08dcdd-24ef-4473-9b46-be1c6408e8d0.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4591M

Santander UK Group Holdings PLC

27 April 2018

NOTIFICATION REGARDING A CHANGE OF PAYING AGENT AND TRANSFER AGENT 

in relation to the SANTANDER UK PLC and

SANTANDER UK GROUP HOLDINGS PLC (each "an Issuer and together the Issuers")

€30,000,000,000 Euro Medium Term Note Programme (the "Programme").

The Issuers hereby announce that with effect from 27 April 2018, Citigroup Global Markets Deutschland AG has resigned as Additional Paying Agent and Transfer Agent in relation to the Notes issued pursuant to the above Programme and has been replaced by Citibank Europe plc. For the avoidance of doubt, Citigroup Global Markets Deutschland AG's appointment as Registrar in relation to the Notes issued pursuant to the above Programme shall continue in full force and effect.

The address of Citibank Europe plc as replacement Paying Agent and Transfer Agent is:

Citibank Europe plc

1 North Wall Quay

Dublin 1

Ireland

For further information, please contact:

Medium Term Funding

2 Triton Square

Regent's Place

London NW1 3AN

Tel: +44 (0) 20 7756 7107

Email: [email protected]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this notice and the documentation relating to the above mentioned Programme may be addressed to and/or targeted at persons who are residents of particular countries (specified in the relevant Final Terms and/or Base Prospectus relating to securities issued under the Programme) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the relevant Final Terms and related Base Prospectus is not addressed. Prior to relying on the information contained in the relevant Base Prospectus and/or Final Terms, you must ascertain from the relevant Base Prospectus and/or Final Terms whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither this notice nor any Base Prospectus or Final Terms relating to the Programmes constitute an offer of securities for sale in the United States. The securities which have been or may be issued under the Programme have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRBUGDSUSDBGIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.